Archives

Twitter-propagated COVID-19 misinformation from credible sources has a huge impact

In March, in the early days of the coronavirus pandemic in Europe, a tweet from the French Health Minister, Olivier Verán, advised patients with COVID-19 not to take ibuprofen, an anti-inflammatory drug with analgesic and antipyretic properties.

Source link Read the rest

Read More

Early-phase Russian trials reveal safety and immunogenicity of two formulations of a two-part vaccine

Results from two early-phase Russian non-randomised vaccine trials (Sputnik V) in a total of 76 people are published today in The Lancet, finding that two formulations of a two-part vaccine have a good safety profile with no serious adverse events detected over 42 days, and induce antibody responses in all participants within 21 days.

Source link Read the rest

Read More

Extra priority should be given to worst-off countries in COVID-19 vaccine allocation, says expert

In contrast to WHO´s and other expert´s advice, the worst-off countries should be extra prioritised when it comes to COVID-19 vaccine allocation, according to Professor Ole Frithjof Norheim at the University of Bergen.

Source link Read the rest

Read More

Study examines the side effects of Alzheimer's disease dementia drugs

In a first of its kind study, a University of Houston researcher is examining two common drugs used for dementia in patients with Alzheimer’s disease to determine the extent to which they don’t mix well together and cause a cascading event of side effects, prompting the need for even more medications.

Source link Read the rest

Read More

BCG vaccine offers protection for elderly people against respiratory infections

The BCG vaccine has a broad, stimulating effect on the immune system. This gives it an effective preventive action against various infections – possibly also against COVID-19. New studies are investigating that.

Source link Read the rest

Read More

Study identifies effective treatment for severe COVID-19 patients

As countries around the world race to develop a vaccine for SARS-CoV-2, the virus responsible for COVID-19, researchers are working to understand exactly how it causes the myriad of symptoms that seem to linger long after active viral infection.

Source link Read the rest

Read More

FDA announces public meeting to discuss development and licensure of COVID-19 vaccines

The U.S. Food and Drug Administration announced that a public meeting of the Vaccines and Related Biological Products Advisory Committee will be held on CutOct. 22, 2020, to discuss the general matter of the development, authorization, and/or licensure of vaccines indicated to prevent COVID-19.

Source link Read the rest

Read More